European Heart Journal最新文献

筛选
英文 中文
Haemodynamic changes after interventional closure of the left atrial appendage may facilitate peri-device leaks. 介入性关闭左心房阑尾后的血流动力学变化可能会导致器械周围渗漏。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2024-11-07 DOI: 10.1093/eurheartj/ehae458
Claudia Stöllberger, Josef Finsterer, Birke Schneider
{"title":"Haemodynamic changes after interventional closure of the left atrial appendage may facilitate peri-device leaks.","authors":"Claudia Stöllberger, Josef Finsterer, Birke Schneider","doi":"10.1093/eurheartj/ehae458","DOIUrl":"10.1093/eurheartj/ehae458","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"4443-4444"},"PeriodicalIF":37.6,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strain surveillance during chemotherapy to improve cardiovascular outcomes: the SUCCOUR-MRI trial. 化疗期间的应变监测以改善心血管预后:SUCCOUR-MRI 试验。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2024-11-07 DOI: 10.1093/eurheartj/ehae574
Thomas H Marwick, Elizabeth Dewar, Mark Nolan, Mitra Shirazi, Peter Dias, Leah Wright, Ben Fitzgerald, Leighton Kearney, Piyush Srivastava, John Atherton, Kazuaki Negishi, Aaron L Sverdlov, Sudhir Wahi, James Otton, Joseph Selvanayagam, Liza Thomas, Paaladinesh Thavendiranathan
{"title":"Strain surveillance during chemotherapy to improve cardiovascular outcomes: the SUCCOUR-MRI trial.","authors":"Thomas H Marwick, Elizabeth Dewar, Mark Nolan, Mitra Shirazi, Peter Dias, Leah Wright, Ben Fitzgerald, Leighton Kearney, Piyush Srivastava, John Atherton, Kazuaki Negishi, Aaron L Sverdlov, Sudhir Wahi, James Otton, Joseph Selvanayagam, Liza Thomas, Paaladinesh Thavendiranathan","doi":"10.1093/eurheartj/ehae574","DOIUrl":"10.1093/eurheartj/ehae574","url":null,"abstract":"<p><strong>Background and aims: </strong>The detection of cancer therapy-related cardiac dysfunction (CTRCD) by reduction of left ventricular ejection fraction (LVEF) during chemotherapy usually triggers the initiation of cardioprotective therapy. This study addressed whether the same approach should be applied to patients with worsening of global longitudinal strain (GLS) without attaining thresholds of LVEF.</p><p><strong>Methods: </strong>Strain surveillance during chemotherapy for improving cardiovascular outcomes (SUCCOUR-MRI) was a prospective multicentre randomized controlled trial involving 14 sites. Of 355 patients receiving anthracyclines with normal baseline LVEF, 333 patients (age 59 ± 13 years, 79% women) with at least one other CTRCD risk factor, able to undergo magnetic resonance imaging (MRI), GLS, and three-dimensional echocardiography were tracked over 12 months. A total of 105 patients (age 59 ± 13 years, 75% women, 69% breast cancer) developing GLS-CTRCD (>12% relative reduction of GLS without a change in LVEF) were randomized to cardioprotection with neurohormonal antagonists vs. usual care. The primary endpoint was 12-month change in MRI-LVEF; the secondary endpoint was MRI-LVEF-defined CTRCD.</p><p><strong>Results: </strong>During follow-up, two patients died, and two developed heart failure. Most patients were randomized at 3 months (62%). Median doses of angiotensin inhibition/blockade and beta-blockade were 75% and 50% of respective targets; 21 (43%) had side-effects attributed to cardioprotection. Due to a smaller LVEF change from baseline with cardioprotection than usual care (-2.5 ± 5.4% vs. -5.6 ± 5.9%, P = .009), follow-up LVEF was higher after cardioprotection (59 ± 5% vs. 55 ± 6%, P < .0001). After adjustment for baseline LVEF, the mean (95% confidence interval) difference in the change in LVEF between the two groups was -3.6% (-1.8% to -5.5%, P < .001). After cardioprotection, 1/49 patients developed 12-month LVEF-CTRCD, compared to 6/56 in usual care (P = .075). Global longitudinal strain improved at 3 months post-randomization in the cardioprotection group, with little change with usual care.</p><p><strong>Conclusions: </strong>In patients with isolated GLS reduction after anthracyclines, cardioprotection is associated with better preservation of 12-month MRI-LVEF compared with usual care.</p>","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"4414-4424"},"PeriodicalIF":37.6,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11542702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142105727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular disease assessment and management in liver transplantation. 肝移植中的心血管疾病评估和管理。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2024-11-07 DOI: 10.1093/eurheartj/ehae502
Matthew E Harinstein, Caterina Gandolfo, Salvatore Gruttadauria, Caterina Accardo, Gonzalo Crespo, Lisa B VanWagner, Abhinav Humar
{"title":"Cardiovascular disease assessment and management in liver transplantation.","authors":"Matthew E Harinstein, Caterina Gandolfo, Salvatore Gruttadauria, Caterina Accardo, Gonzalo Crespo, Lisa B VanWagner, Abhinav Humar","doi":"10.1093/eurheartj/ehae502","DOIUrl":"10.1093/eurheartj/ehae502","url":null,"abstract":"<p><p>The prevalence and mortality related to end-stage liver disease (ESLD) continue to rise globally. Liver transplant (LT) recipients continue to be older and have inherently more comorbidities. Among these, cardiac disease is one of the three main causes of morbidity and mortality after LT. Several reasons exist including the high prevalence of associated risk factors, which can also be attributed to the rise in the proportion of patients undergoing LT for metabolic dysfunction-associated steatohepatitis (MASH). Additionally, as people age, the prevalence of now treatable cardiac conditions, including coronary artery disease (CAD), cardiomyopathies, significant valvular heart disease, pulmonary hypertension, and arrhythmias rises, making the need to treat these conditions critical to optimize outcomes. There is an emerging body of literature regarding CAD screening in patients with ESLD, however, there is a paucity of strong evidence to support the guidance regarding the management of cardiac conditions in the pre-LT and perioperative settings. This has resulted in significant variations in assessment strategies and clinical management of cardiac disease in LT candidates between transplant centres, which impacts LT candidacy based on a transplant centre's risk tolerance and comfort level for caring for patients with concomitant cardiac disease. Performing a comprehensive assessment and understanding the potential approaches to the management of ESLD patients with cardiac conditions may increase the acceptance of patients, who appear too complex, but rather require extra evaluation and may be reasonable candidates for LT. The unique physiology of ESLD can profoundly influence preoperative assessment, perioperative management, and outcomes associated with underlying cardiac pathology, and requires a thoughtful multidisciplinary approach. The strategies proposed in this manuscript attempt to review the latest expert experience and opinions and provide guidance to practicing clinicians who assess and treat patients being considered for LT. These topics also highlight the gaps that exist in the comprehensive care of LT patients and the need for future investigations in this field.</p>","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"4399-4413"},"PeriodicalIF":37.6,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From setbacks to success: building a promising path for strain-guided cardioprotection during anthracycline treatment. 从挫折到成功:为蒽环类药物治疗期间应变引导的心脏保护开辟一条前景广阔的道路。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2024-11-07 DOI: 10.1093/eurheartj/ehae598
Ana Barac, Lauren Mauro, Kathleen Harnden
{"title":"From setbacks to success: building a promising path for strain-guided cardioprotection during anthracycline treatment.","authors":"Ana Barac, Lauren Mauro, Kathleen Harnden","doi":"10.1093/eurheartj/ehae598","DOIUrl":"10.1093/eurheartj/ehae598","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"4425-4427"},"PeriodicalIF":37.6,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142105684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The challenge of cancer therapy-related cardiac dysfunction: facts and perspectives. 癌症治疗相关心脏功能障碍的挑战:事实与观点。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2024-11-07 DOI: 10.1093/eurheartj/ehae735
Filippo Crea
{"title":"The challenge of cancer therapy-related cardiac dysfunction: facts and perspectives.","authors":"Filippo Crea","doi":"10.1093/eurheartj/ehae735","DOIUrl":"https://doi.org/10.1093/eurheartj/ehae735","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"45 41","pages":"4355-4358"},"PeriodicalIF":37.6,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142603291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left atrial appendage occlusion leaks matter: the cryptic interplay of post-procedural haemodynamic changes and device surveillance. 左心房阑尾闭塞泄漏问题:术后血流动力学变化与设备监控的隐秘相互作用。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2024-11-07 DOI: 10.1093/eurheartj/ehae459
Athanasios Samaras, Apostolos Tzikas
{"title":"Left atrial appendage occlusion leaks matter: the cryptic interplay of post-procedural haemodynamic changes and device surveillance.","authors":"Athanasios Samaras, Apostolos Tzikas","doi":"10.1093/eurheartj/ehae459","DOIUrl":"10.1093/eurheartj/ehae459","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"4445-4446"},"PeriodicalIF":37.6,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pregnancy in obese women and mechanisms of increased cardiovascular risk in offspring 肥胖妇女妊娠和后代心血管风险增加的机制
IF 39.3 1区 医学
European Heart Journal Pub Date : 2024-11-07 DOI: 10.1093/eurheartj/ehae671
Anna L K Cochrane, Michael P Murphy, Susan E Ozanne, Dino A Giussani
{"title":"Pregnancy in obese women and mechanisms of increased cardiovascular risk in offspring","authors":"Anna L K Cochrane, Michael P Murphy, Susan E Ozanne, Dino A Giussani","doi":"10.1093/eurheartj/ehae671","DOIUrl":"https://doi.org/10.1093/eurheartj/ehae671","url":null,"abstract":"Pregnancy complicated by maternal obesity contributes to an increased cardiovascular risk in offspring, which is increasingly concerning as the rates of obesity and cardiovascular disease are higher than ever before and still growing. There has been much research in humans and preclinical animal models to understand the impact of maternal obesity on offspring health. This review summarizes what is known about the offspring cardiovascular phenotype, describing a mechanistic role for oxidative stress, metabolic inflexibility, and mitochondrial dysfunction in mediating these impairments. It also discusses the impact of secondary postnatal insults, which may reveal latent cardiovascular deficits that originated in utero. Finally, current interventional efforts and gaps of knowledge to limit the developmental origins of cardiovascular dysfunction in offspring of obese pregnancy are highlighted.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"24 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Weekly Journal Scan: A reassuring answer to questions about statin therapy and diabetes. 每周期刊扫描:他汀类药物治疗与糖尿病问题的答案令人欣慰。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2024-11-07 DOI: 10.1093/eurheartj/ehae486
Daniela Pedicino, Massimo Volpe
{"title":"Weekly Journal Scan: A reassuring answer to questions about statin therapy and diabetes.","authors":"Daniela Pedicino, Massimo Volpe","doi":"10.1093/eurheartj/ehae486","DOIUrl":"10.1093/eurheartj/ehae486","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"4449-4450"},"PeriodicalIF":37.6,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141897203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypertrophic cardiomyopathy evolving management: American Heart Association/American College of Cardiology vs. European Society of Cardiology guidelines. 肥厚型心肌病的演变管理:美国心脏协会/美国心脏病学会与欧洲心脏病学会指南对比。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2024-11-06 DOI: 10.1093/eurheartj/ehae507
Edoardo Bertero, Marco Canepa, Iacopo Olivotto
{"title":"Hypertrophic cardiomyopathy evolving management: American Heart Association/American College of Cardiology vs. European Society of Cardiology guidelines.","authors":"Edoardo Bertero, Marco Canepa, Iacopo Olivotto","doi":"10.1093/eurheartj/ehae507","DOIUrl":"https://doi.org/10.1093/eurheartj/ehae507","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":""},"PeriodicalIF":37.6,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The ESC Textbook of Heart Failure: breaking the new educational frontier. ESC心力衰竭教科书:突破教育新领域。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2024-11-06 DOI: 10.1093/eurheartj/ehad897
Petar M Seferovic, Andrew J S Coats, Gerasimos Filippatos
{"title":"The ESC Textbook of Heart Failure: breaking the new educational frontier.","authors":"Petar M Seferovic, Andrew J S Coats, Gerasimos Filippatos","doi":"10.1093/eurheartj/ehad897","DOIUrl":"https://doi.org/10.1093/eurheartj/ehad897","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":""},"PeriodicalIF":37.6,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信